The AstraZeneca BioVentureHub in Mölndal is a new approach for open innovation. The company opens up their offices, laboratory space and facilities to academic groups and biotech companies that could gain competitive advantage by tapping into the company’s resources and expertise. The set-up is a win-win situation for all parties involved: the company/academic group, its investors and AstraZeneca. Companies and academic groups can operate at a lower cost base, utilise the AstraZeneca capabilities, know-how and infrastructure. AstraZeneca will request value recognition for its contribution only at success of the program.